VAERS Explorer
Back to explore

Report #2860614

Received Sep 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
WI
Recovered
Unknown
Vaccinated
Aug 22, 2025
Onset
Aug 22, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNK2M7GR—

Symptoms (1)

Product preparation issue

Symptom narrative

suspect they got two vials of the liquid part of the shingrix vaccine; suspect they got two vials of the liquid part of the shingrix vaccine; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 62-year-old female patient who received Herpes zoster (Shingrix) (batch number 2M7GR, expiry date 31-JAN-2027) for prophylaxis. On 22-AUG-2025, the patient received Shingrix. On 22-AUG-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: suspect they got two vials of the liquid part of the shingrix vaccine) and inappropriate dose of vaccine administered (Verbatim: suspect they got two vials of the liquid part of the shingrix vaccine). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 26-AUG-2025 and 27-AUG-2025 Pharmacist contacted that had a patient who received a vaccine with another pharmacist. However they suspect they got two vials of the liquid part of the Shingrix vaccine. Instead of reconstitution of the vaccine with one liquid and one powder Inappropriate preparation of medication and Inappropriate dose of vaccine administered. The administration of the 2 diluents only of Shingrix was last Friday on 22 Aug 2025.